Data / Form D filings / Viroxis Corp
Viroxis Corp: Form D filings
Viroxis Corp, a pharmaceuticals company in San Antonio, TX, filed 6 Form D notices with the SEC between 2010 and 2013. The latest, on April 22, 2013, reports $7.8 million sold of a $7.8 million offering to 43 investors.
Find out what Viroxis Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18618 Tuscany Stone, Suite 100, San Antonio, TX, 78258
- Phone
- (210) 558-8896
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Texas
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1480932
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 22, 2013 | Amendment | $7,795,000 | $7,795,000 | $0 | 43 | Feb 23, 2012 | sec.gov |
| Apr 11, 2013 | Amendment | $7,795,000 | $7,795,000 | $0 | 43 | Feb 23, 2012 | sec.gov |
| Mar 8, 2012 | New notice | $10,000,000 | $1,010,000 | $8,990,000 | 6 | Feb 23, 2012 | sec.gov |
| Oct 18, 2010 | New notice | $2,500,000 | $1,250,000 | $1,250,000 | 1 | Oct 1, 2010 | sec.gov |
| May 26, 2010 | New notice | $1,500,000 | $772,685 | $727,315 | 1 | May 18, 2010 | sec.gov |
| Jan 14, 2010 | New notice | $500,700 | $500,700 | $0 | 1 | Dec 31, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul William David Castella | Director, Promoter | |
| Cathy William David Burzik | Director | |
| Charles William David Goodrich | Director | |
| Ian William David Clements | Executive Officer, Director | |
| Gary William David Frashier | Director | |
| Alan William David Dean | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Apr 22, 2013 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Viroxis Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.